To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Nuvo Research Announces New Listing of Synera® Patent in FDA Orange Book
Nuvo Research Inc. has announced that the United States Patent Office has granted the reinstatement of Patent No. 6,465,709 related to Synera® Patch (Synera Patent).
Nuvo has listed the Synera Patent in the U.S. Food and Drug Administration's (FDA) Orange Book.
The Orange Book listing requires an Abbreviated New Drug Application (ANDA) applicant seeking FDA approval for a generic version of Synera prior to expiration of the patent to notify Nuvo of its ANDA filing before it can obtain FDA approval.
"We are very pleased that we have received additional patent protection for Synera Patch in the U.S.," said Tina Loucaides, Nuvo's Vice-President and General Counsel.
Loucaides continued, "The listing of this patent in the FDA Orange Book provides us with significantly more years of protection and will allow us to better explore expanded indications for this unique topical local anesthetic patch."
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
